Florian Colbatzky

This inventor holds 8 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Boehringer Ingelheim Pharma Gmbh & Co Kg. Active years: 2005-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Florian Colbatzky. Retrieved from https://idiyas.com/inventor/florian-colbatzky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8

% Patents Active = 75.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 168(Granted Patents)

Location History:

Stafflangen, DE (2005 - 2011)
Stafflagen, DE (2013)

Company Filing History:

8 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

Years Active: 2005-2013

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8431585 - Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH)/prostatic hypertrophy (2013-04-30),

2. 8003786 - Dihydropteridinone compounds (2011-08-23),

3. 7989474 - Use of Lck inhibitors for treatment of immunologic diseases (2011-08-02),

4. 7786299 - Methods for treating diseases or conditions using dihydropteridinone compounds (2010-08-31),

5. 7750152 - Intermediate compounds for making dihydropteridinones useful as pharmaceutical compositions and processes of making the same (2010-07-06),

6. 7189743 - Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amide (2007-03-13),

7. 6900229 - Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amide (2005-05-31),

8. 6861422 - Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions (2005-03-01),

Sure, here is the article about inventor Florian Colbatzky:

Title: Florian Colbatzky - Innovator in Pharmaceutical Research

Introduction:

Florian Colbatzky, a renowned inventor in the field of pharmaceuticals, hails from Stafflangen, Germany. With a total of eight patents to his name, his contributions have significantly impacted the treatment of various medical conditions.

Latest Patents:

Colbatzky's recent patents showcase his expertise in the pharmaceutical domain. One of his latest inventions involves the use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH) and prostatic hypertrophy. This novel approach highlights his dedication to finding innovative solutions for prevalent health issues. Additionally, his work on dihydropteridinone compounds demonstrates his versatility in developing new pharmaceutical compositions.

Career Highlights:

Currently affiliated with Boehringer Ingelheim Pharma GmbH & Co. KG, Florian Colbatzky has made a name for himself as a key figure in the company's research and development division. His innovative mindset and strong work ethic have led to the successful filing of multiple patents, solidifying his position as a leading inventor in the pharmaceutical industry.

Collaborations:

Throughout his career, Colbatzky has collaborated closely with industry peers such as Matthias Grauert and Martin Steegmaier. These partnerships have been instrumental in pushing the boundaries of pharmaceutical research and bringing groundbreaking ideas to fruition.

Conclusion:

In conclusion, Florian Colbatzky's dedication to innovation and his contributions to the field of pharmaceuticals have earned him a well-deserved reputation as a pioneering inventor. His latest patents stand as a testament to his commitment to advancing medical treatments and improving patient outcomes.

Profile summary based on public USPTO records.